OneAscent Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
OneAscent Wealth Management's BMY Position: Q3 2026 in Review
OneAscent Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q3 2026, selling an estimated $67.6K and leaving 4,874 shares worth $304K. The position accounts for 0.1% of the portfolio, ranked #100.
OneAscent Wealth Management first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $409K in Q4 2022. 2,126 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- OneAscent Wealth Management held 4,874 shares of Bristol-Myers Squibb worth $304K as of Q3 2026.
- OneAscent Wealth Management sold 1,069 Bristol-Myers Squibb shares in Q3 2026, an estimated $67.6K.
- Bristol-Myers Squibb made up 0.1% of OneAscent Wealth Management's portfolio in Q3 2026, its #100 holding.
- OneAscent Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
- OneAscent Wealth Management's Bristol-Myers Squibb position peaked at $409K in Q4 2022.
- 2,126 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on OneAscent Wealth Management's 13F filing for Q3 2026, filed 10 Nov 2026.